Approved Hospital Formulary
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

pneumococcal 13-valent conjugate vaccine

pneumococcal 13-valent conjugate vaccine
Brand names: Prevnar 13
Form Strength
SUSPENSION, INTRAMUSCULAR -

VIEW MORE Vaccines
CLASS
801200

Additional Information:

Storage, Monitoring and Handing of Refrigerated or Frozen Medications and Vaccines: See Policy 916.3910

Current VIS: CDC Vaccine Information Sheet (PCV13)

  • Pneumococcal conjugate vaccine 20-valent (Prevnar 20)
    • Provides the broadest coverage of pneumococcal serotypes available as a conjugate vaccine 
    • In June 2023, ACIP recommended PCV20 for
      • Routine childhood vaccination (4 dose series for children 2-23 months old)
      • Vaccination in children age2-18 years with underlying medical conditions
      • Catch up vaccination 
  • PCV20 is currently formulary and used for adult vaccination, with the updated indications from ACIP it will be available for use in pediatric patients as well 

Last updated: Feb. 13, 2024







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.